Predicting decline in left ventricular function after new-onset left bundle branch block
Dylan Goings1, Patricia Carey1, Tristan Meier2
1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Artificial intelligence-derived ECG markers predict left ventricular ejection fraction decline in patients with left bundle branch block. This aids early detection and intervention for heart dysfunction.
Area of Science:
- Cardiology
- Artificial Intelligence in Medicine
- Medical Diagnostics
Background:
- Left bundle branch block (LBBB) is linked to increased risk of left ventricular systolic dysfunction.
- Early identification of high-risk patients with LBBB is crucial for timely management.
Purpose of the Study:
- To identify predictors of significant left ventricular ejection fraction (LVEF) decline in LBBB patients.
- Utilize clinical, echocardiographic, and electrocardiographic (ECG) data for prediction.
Main Methods:
- Retrospective analysis of 769 patients with new LBBB and preserved LVEF (≥50%).
- Cox proportional hazards regression to identify predictors of ≥20% LVEF decline.
- Construction of a risk prediction model.
Main Results:
- 31.5% of patients experienced ≥20% LVEF decline over a median of 4.9 years.
- AI-derived ECG scores for LV systolic and diastolic dysfunction independently predicted LVEF decline.
- The predictive model showed modest discriminative ability (C-index 0.615-0.70).
Conclusions:
- AI-derived ECG markers for LV systolic and diastolic dysfunction predict future LVEF decline in new-onset LBBB.
- Echocardiographic parameters can further enhance risk stratification.
- This framework supports monitoring and early intervention in LBBB patients.
More Related Videos
06:34Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
08:19Transthoracic Echocardiography to Assess Post-Resuscitation Left Ventricular Dysfunction After Acute Myocardial Infarction and Cardiac Arrest in Pigs
Published on: July 12, 2022
Related Concept Videos
Mitral Stenosis I: Introduction
Heart Failure Drugs: β-Blockers
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
